Xenetic Biosciences Appoints New Auditor
Ticker: XBIO · Form: 8-K · Filed: Apr 10, 2025 · CIK: 1534525
| Field | Detail |
|---|---|
| Company | Xenetic Biosciences, Inc. (XBIO) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, 8-k
Related Tickers: XBIO
TL;DR
Xenetic Biosciences just switched auditors to Marcum LLP, effective April 8, 2025.
AI Summary
On April 8, 2025, Xenetic Biosciences, Inc. filed an 8-K report to disclose changes in its certifying accountant. The company has appointed Marcum LLP as its new independent registered public accounting firm, effective April 8, 2025. This change follows the resignation of the previous auditor, WithumSmith+Brown, PC.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.
Risk Assessment
Risk Level: low — This filing pertains to a routine change in the company's auditor, which typically carries low immediate risk.
Key Players & Entities
- Xenetic Biosciences, Inc. (company) — Registrant
- Marcum LLP (company) — New Certifying Accountant
- WithumSmith+Brown, PC (company) — Former Certifying Accountant
- April 8, 2025 (date) — Effective date of auditor change
FAQ
When was the change in certifying accountant effective?
The change in certifying accountant was effective April 8, 2025.
Who is the new independent registered public accounting firm for Xenetic Biosciences?
The new independent registered public accounting firm is Marcum LLP.
Who was Xenetic Biosciences' previous certifying accountant?
The previous certifying accountant for Xenetic Biosciences was WithumSmith+Brown, PC.
What type of SEC filing is this?
This is a Form 8-K, a current report.
What is the principal executive office address for Xenetic Biosciences?
The principal executive office address is 945 Concord Street, Framingham, Massachusetts 01701.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding Xenetic Biosciences, Inc. (XBIO).